Dr. Michaela Medová: Molecular Determinants of Radiotherapy Responses

You are warmly invited to a lecture by Dr. Michaela Medová entitled “Molecular Determinants of Radiotherapy Responses.” We look forward to welcoming you on 14 October 2026 at 10:30 a.m. in the Brdička Lecture Hall at the Heyrovský Institute.

Despite major technological breakthroughs in precision radiation delivery, treatment resistance driven by altered DNA damage response signaling remains a major barrier to long-term cancer control. Understanding these molecular resistance mechanisms is essential to improving patient outcomes. In this seminar, we will discuss our recent research into the molecular determinants of radiosensitivity and outline concrete strategies for biomarker-driven tumor radiosensitization to enhance conventional radiation therapies.

PD Dr. Michaela Medová, PhD, is Head of Research at the Department of Radiation Oncology, Inselspital, Bern University Hospital. She holds an MSc in Biomedical Physics from Comenius University in Bratislava and a PhD in Biomedical and Cellular Sciences from the University of Bern. Her research investigates the molecular mechanisms driving cancer development and progression, with a focus on translating these insights into personalized therapies combined with conventional DNA-damaging treatments.